In partnership with

Hello. It's November 15.

Millions of people take a statin (a cholesterol-lowering pill) for years. Then they hit their 70s and wonder: can I stop? A big new trial just tried to answer that. The answer is more "it depends" than yes or no.

The rundown:

  • Oura to pay $625 million to put doctors behind its smart ring

  • A once-daily pill cut sleep apnea severity in two big trials

  • A Stanford brain-wiring score flagged Alzheimer's risk up to 12 years early

  • Five different anti-aging treatments in mice all raised the same mushroom antioxidant

Let's get to it. 👇

turn back the clock

A Stanford team built a brain-wiring score that flagged Alzheimer's risk up to 12 years early - the "ARC" score, drawn from resting brain scans, matched or beat genetic and plaque-based tests at spotting who would decline. It's a research tool for now, not a clinic test. Open Access Government

Five different lifespan-extending treatments in mice all raised the same mushroom-derived antioxidant, ergothioneine - in blood and brain. It's a correlation in male mice, so it doesn't prove ergothioneine is doing the work. Medical Xpress

Insilico Medicine, an AI drug-discovery company, released a free tool called Longevity Grok that pulls your lab results, wearable data and health records into one view - built with Harvard geneticist David Sinclair, one of the best-known names in aging research. The code is public for anyone to inspect. PR Newswire

The Lancet Healthy Longevity published a three-paper series on exercise for older adults - including a review of "exercise snacks," short, harder bursts of movement spread through the day. The Lancet Healthy Longevity

The peptide gold rush is on - last issue we covered a new US policy letting doctors and pharmacies custom-make six popular peptides. Longevity brand Elysium Health said it would sell all six; now telehealth company AgelessRx has launched doctor-supervised injection plans for three of them (BPC-157, TB-500 and MOTS-c). Two companies in a week, on a policy barely three weeks old. Business Wire

FROM THE CLINIC

Should Older Adults Stop Taking Statins?

Statins are some of the most-taken pills on Earth, but most trials didn't include many people over 70. A new one, STREAM, finally asked: what happens if older adults just stop?

STREAM was published in the New England Journal of Medicine and presented at the American Heart Association meeting on November 7. It followed 1,880 people aged 70 and up (average age 77) who took a statin to prevent a first heart attack or stroke and had at least two chronic conditions. Some kept taking it. Some stopped.

What it found:

  • After two years, stopping was "noninferior" - doctor-speak for "not meaningfully worse" - on heart events or death.

  • Over the full follow-up (up to about four years), more people who stopped had a heart event or died: 12.7% versus 9.2% for those who kept going.

  • Stopping didn't make people feel better. There was no real difference in quality of life, pain, falls or muscle problems.

The catch: it was open-label (everyone knew what they were taking), and it only covered older adults with several chronic conditions and no previous heart attack or stroke. After the trial, the safety board told the stop group to talk to their doctors about restarting.

Why it matters: stopping isn't free, and it isn't a disaster either. A Duke cardiologist who discussed the trial said it supports continuing statins people tolerate, with deprescribing (stopping medicines on purpose) done selectively. Don't quit on your own - talk to your doctor.

👉 TCTMD | HCPLive

UP YOUR LONGEVITY GAME

Mobility: The Underrated Lever for Longevity

You can train hard and eat well and still wake up stiff at 50.

Mobility is the part of healthspan most people skip - until their back, knees or hips make the decision for them.

pliability is the #1 mobility app: 2,000+ routines, 4M+ downloads, 10,000+ five-star ratings. Tell it what hurts and how long you've got, and it builds the session.

30% More Mobility in 2 Weeks. That's what pliability's own data shows for people who stretched at least three times a week. Twelve minutes a day, guided start to finish, no equipment needed.

Seven days free. Cancel anytime. HSA and FSA eligible.

IN THE NEWS

A Daily Pill Cut Sleep Apnea Severity in Big Trials

Sleep apnea means your breathing repeatedly stops or turns shallow while you sleep. The standard fix is CPAP (a mask that blows air), but plenty of people can't tolerate it. Now a once-daily oral GLP-1 weight-loss pill, orforglipron (brand name Foundayo), has results for it.

In two Lilly-funded phase 3 trials of 712 adults with obesity and moderate to severe sleep apnea, published November 9 in JAMA, breathing interruptions per hour fell about 35% on the pill versus 5% on placebo among people not using CPAP (26% versus 3% among CPAP users). Weight dropped roughly 10 to 11%, and blood pressure improved.

The results don't show it can replace CPAP, and the trials ran 52 weeks and were company-funded. Lilly plans to ask the FDA to approve it for sleep apnea by the end of 2026. Zepbound, a weekly injection, is already approved for this.

👉 Healio | TCTMD

LONGEVITY BIZ

Oura Is Buying Its Way Into Primary Care

Smart ring maker Oura agreed to buy Counsel Health, an AI-powered virtual primary care company, for $625 million in cash. Counsel pairs a medical chatbot with real doctors who can give clinical guidance, diagnoses, prescriptions and referrals. The deal is expected to close before the end of 2026.

The logic: Oura has the data (continuous readings from more than six million members) and Counsel has the clinicians. A ring that tells you what's happening could now also help you do something about it. The deal comes weeks after Oura put its planned IPO on hold, citing market uncertainty.

The open question is whether people want medical care from their wearable.

CHECK YOUR STACK

Self-care in 10 minutes a day, now 25% off

Looking for an easy way to elevate your daily skincare routine? Meet the BON CHARGE Red Light Face Mask.

Designed with optimal wavelengths of 630nm red light and 850nm near infrared light, it's a simple addition to your routine to support more radiant, glowing skin. Suitable for all skin types, the lightweight mask contours comfortably to your face and can be used for just 10 minutes a day. Whether you're reading a book, winding down at home or packing for your next trip, it's an effortless way to prioritise a little self-care. BON CHARGE combines innovative wellness technology with science-backed research to create premium products that make looking after yourself easier.

Shop the BON CHARGE Black Friday Sale and enjoy 25% off sitewide. Click the link to explore the range, with your discount automatically applied

BIOHACK BOOKS

Super Agers

Eric Topol

This week's Stanford brain study compared "SuperAgers" - people over 75 whose memory matches healthy 50-year-olds. Cardiologist Eric Topol's book goes after the bigger question: what really separates people who age unusually well from the rest of us? Evidence first, hype second.

Your tweet sized thoughts of the week.

Daylight = underrated 👇

Affiliate disclaimer: This newsletter may contain affiliate links that earn us a commission upon sale at no extra cost to you. This helps support the newsletter.

Medical Disclaimer: This newsletter is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health protocol. Content may contain errors, may become outdated, and we are not responsible for information provided by third-party sources. Any action taken based on this content is strictly at your own risk.